Skip to main content
Top
Published in: Respiratory Research 1/2011

Open Access 01-12-2011 | Research

Role of the gap junctions in the contractile response to agonists in pulmonary artery from two rat models of pulmonary hypertension

Authors: Marie Billaud, Diana Dahan, Roger Marthan, Jean-Pierre Savineau, Christelle Guibert

Published in: Respiratory Research | Issue 1/2011

Login to get access

Abstract

Background

Pulmonary hypertension (PH) is characterized by arterial vascular remodelling and alteration in vascular reactivity. Since gap junctions are formed with proteins named connexins (Cx) and contribute to vasoreactivity, we investigated both expression and role of Cx in the pulmonary arterial vasoreactivity in two rat models of PH.

Methods

Intrapulmonary arteries (IPA) were isolated from normoxic rats (N), rats exposed to chronic hypoxia (CH) or treated with monocrotaline (MCT). RT-PCR, Western Blot and immunofluorescent labelling were used to study the Cx expression. The role of Cx in arterial reactivity was assessed by using isometric contraction and specific gap junction blockers. Contractile responses were induced by agonists already known to be involved in PH, namely serotonin, endothelin-1 and phenylephrine.

Results

Cx 37, 40 and 43 were expressed in all rat models and Cx43 was increased in CH rats. In IPA from N rats only, the contraction to serotonin was decreased after treatment with 37-43Gap27, a specific Cx-mimetic peptide blocker of Cx 37 and 43. The contraction to endothelin-1 was unchanged after incubation with 40Gap27 (a specific blocker of Cx 40) or 37-43Gap27 in N, CH and MCT rats. In contrast, the contraction to phenylephrine was decreased by 40Gap27 or 37-43Gap27 in CH and MCT rats. Moreover, the contractile sensitivity to high potassium solutions was increased in CH rats and this hypersensitivity was reversed following 37-43Gap27 incubation.

Conclusion

Altogether, Cx 37, 40 and 43 are differently expressed and involved in the vasoreactivity to various stimuli in IPA from different rat models. These data may help to understand alterations of pulmonary arterial reactivity observed in PH and to improve the development of innovative therapies according to PH aetiology.
Appendix
Available only for authorised users
Literature
1.
go back to reference Goodenough DA, Paul DL: Gap junctions. Cold Spring Harbor Perspect Biol. 2009, 1: a002576-10.1101/cshperspect.a002576.CrossRef Goodenough DA, Paul DL: Gap junctions. Cold Spring Harbor Perspect Biol. 2009, 1: a002576-10.1101/cshperspect.a002576.CrossRef
2.
go back to reference Cottrell GT, Burt JM: Functional consequences of heterogeneous gap junction channel formation and its influence in health and disease. Biochim Biophys Acta. 2005, 1711: 126-141. 10.1016/j.bbamem.2004.11.013.CrossRefPubMed Cottrell GT, Burt JM: Functional consequences of heterogeneous gap junction channel formation and its influence in health and disease. Biochim Biophys Acta. 2005, 1711: 126-141. 10.1016/j.bbamem.2004.11.013.CrossRefPubMed
3.
4.
go back to reference Rummery NM, Hill CE: Vascular gap junctions and implications for hypertension. Clin Exp Pharmacol Physiol. 2004, 31: 659-667. 10.1111/j.1440-1681.2004.04071.x.CrossRefPubMed Rummery NM, Hill CE: Vascular gap junctions and implications for hypertension. Clin Exp Pharmacol Physiol. 2004, 31: 659-667. 10.1111/j.1440-1681.2004.04071.x.CrossRefPubMed
5.
go back to reference Cowan DB, Jones M, Garcia LM, Noria S, del Nido PJ, McGowan FX: Hypoxia and stretch regulate intercellular communication in vascular smooth muscle cells through reactive oxygen species formation. Arterioscler Thromb Vasc Biol. 2003, 23: 1754-1760. 10.1161/01.ATV.0000093546.10162.B2.CrossRefPubMed Cowan DB, Jones M, Garcia LM, Noria S, del Nido PJ, McGowan FX: Hypoxia and stretch regulate intercellular communication in vascular smooth muscle cells through reactive oxygen species formation. Arterioscler Thromb Vasc Biol. 2003, 23: 1754-1760. 10.1161/01.ATV.0000093546.10162.B2.CrossRefPubMed
6.
go back to reference Humbert M, Sitbon O, Simonneau G: Treatment of pulmonary arterial hypertension. N Engl J Med. 2004, 351: 1425-1436. 10.1056/NEJMra040291.CrossRefPubMed Humbert M, Sitbon O, Simonneau G: Treatment of pulmonary arterial hypertension. N Engl J Med. 2004, 351: 1425-1436. 10.1056/NEJMra040291.CrossRefPubMed
7.
go back to reference Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R: Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009, 54: S43-54. 10.1016/j.jacc.2009.04.012.CrossRefPubMed Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R: Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009, 54: S43-54. 10.1016/j.jacc.2009.04.012.CrossRefPubMed
8.
go back to reference Humbert M: Update in pulmonary hypertension 2008. Am J Respir Crit Care Med. 2009, 179: 650-656. 10.1164/rccm.200901-0136UP.CrossRefPubMed Humbert M: Update in pulmonary hypertension 2008. Am J Respir Crit Care Med. 2009, 179: 650-656. 10.1164/rccm.200901-0136UP.CrossRefPubMed
9.
go back to reference Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ: Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993, 328: 1732-1739. 10.1056/NEJM199306173282402.CrossRefPubMed Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ: Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993, 328: 1732-1739. 10.1056/NEJM199306173282402.CrossRefPubMed
10.
go back to reference Herve P, Launay JM, Scrobohaci ML, Brenot F, Simonneau G, Petitpretz P, Poubeau P, Cerrina J, Duroux P, Drouet L: Increased plasma serotonin in primary pulmonary hypertension. Am J Med. 1995, 99: 249-254. 10.1016/S0002-9343(99)80156-9.CrossRefPubMed Herve P, Launay JM, Scrobohaci ML, Brenot F, Simonneau G, Petitpretz P, Poubeau P, Cerrina J, Duroux P, Drouet L: Increased plasma serotonin in primary pulmonary hypertension. Am J Med. 1995, 99: 249-254. 10.1016/S0002-9343(99)80156-9.CrossRefPubMed
11.
go back to reference Hosoda Y: Pathology of pulmonary hypertension: a human and experimental study. Pathol Int. 1994, 44: 241-267. 10.1111/j.1440-1827.1994.tb03363.x.CrossRefPubMed Hosoda Y: Pathology of pulmonary hypertension: a human and experimental study. Pathol Int. 1994, 44: 241-267. 10.1111/j.1440-1827.1994.tb03363.x.CrossRefPubMed
12.
go back to reference Kanai Y, Hori S, Tanaka T, Yasuoka M, Watanabe K, Aikawa N, Hosoda Y: Role of 5-hydroxytryptamine in the progression of monocrotaline induced pulmonary hypertension in rats. Cardiovasc Res. 1993, 27: 1619-1623. 10.1093/cvr/27.9.1619.CrossRefPubMed Kanai Y, Hori S, Tanaka T, Yasuoka M, Watanabe K, Aikawa N, Hosoda Y: Role of 5-hydroxytryptamine in the progression of monocrotaline induced pulmonary hypertension in rats. Cardiovasc Res. 1993, 27: 1619-1623. 10.1093/cvr/27.9.1619.CrossRefPubMed
13.
go back to reference Miyauchi T, Yorikane R, Sakai S, Sakurai T, Okada M, Nishikibe M, Yano M, Yamaguchi I, Sugishita Y, Goto K: Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res. 1993, 73: 887-897.CrossRefPubMed Miyauchi T, Yorikane R, Sakai S, Sakurai T, Okada M, Nishikibe M, Yano M, Yamaguchi I, Sugishita Y, Goto K: Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res. 1993, 73: 887-897.CrossRefPubMed
14.
go back to reference Salvi SS: Alpha1-adrenergic hypothesis for pulmonary hypertension. Chest. 1999, 115: 1708-1719. 10.1378/chest.115.6.1708.CrossRefPubMed Salvi SS: Alpha1-adrenergic hypothesis for pulmonary hypertension. Chest. 1999, 115: 1708-1719. 10.1378/chest.115.6.1708.CrossRefPubMed
15.
go back to reference Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, Rabinovitch M: Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 2004, 43: 13S-24S. 10.1016/j.jacc.2004.02.029.CrossRefPubMed Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O, Voelkel NF, Rabinovitch M: Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 2004, 43: 13S-24S. 10.1016/j.jacc.2004.02.029.CrossRefPubMed
16.
go back to reference Shimoda LA, Sham JS, Sylvester JT: Altered pulmonary vasoreactivity in the chronically hypoxic lung. Physiol Res. 2000, 49: 549-560.PubMed Shimoda LA, Sham JS, Sylvester JT: Altered pulmonary vasoreactivity in the chronically hypoxic lung. Physiol Res. 2000, 49: 549-560.PubMed
17.
go back to reference Guibert C, Marthan R, Savineau JP: Modulation of ion channels in pulmonary arterial hypertension. Curr Pharm Des. 2007, 13: 2443-2455. 10.2174/138161207781368585.CrossRefPubMed Guibert C, Marthan R, Savineau JP: Modulation of ion channels in pulmonary arterial hypertension. Curr Pharm Des. 2007, 13: 2443-2455. 10.2174/138161207781368585.CrossRefPubMed
18.
go back to reference Billaud M, Marthan R, Savineau JP, Guibert C: Vascular smooth muscle modulates endothelial control of vasoreactivity via reactive oxygen species production through myoendothelial communications. PLoS One. 2009, 4: e6432-10.1371/journal.pone.0006432.CrossRefPubMedPubMedCentral Billaud M, Marthan R, Savineau JP, Guibert C: Vascular smooth muscle modulates endothelial control of vasoreactivity via reactive oxygen species production through myoendothelial communications. PLoS One. 2009, 4: e6432-10.1371/journal.pone.0006432.CrossRefPubMedPubMedCentral
19.
go back to reference Chaytor AT, Evans WH, Griffith TM: Peptides homologous to extracellular loop motifs of connexin 43 reversibly abolish rhythmic contractile activity in rabbit arteries. J Physiol. 1997, 503 (Pt 1): 99-110. 10.1111/j.1469-7793.1997.099bi.x.CrossRefPubMedPubMedCentral Chaytor AT, Evans WH, Griffith TM: Peptides homologous to extracellular loop motifs of connexin 43 reversibly abolish rhythmic contractile activity in rabbit arteries. J Physiol. 1997, 503 (Pt 1): 99-110. 10.1111/j.1469-7793.1997.099bi.x.CrossRefPubMedPubMedCentral
20.
go back to reference Tual-Chalot S, Guibert C, Muller B, Savineau JP, Andriantsitohaina R, Martinez MC: Circulating Microparticles from Pulmonary Hypertensive Rats Induce Endothelial Dysfunction. Am J Respir Crit Care Med. 2010, 182: 261-268. 10.1164/rccm.200909-1347OC.CrossRefPubMed Tual-Chalot S, Guibert C, Muller B, Savineau JP, Andriantsitohaina R, Martinez MC: Circulating Microparticles from Pulmonary Hypertensive Rats Induce Endothelial Dysfunction. Am J Respir Crit Care Med. 2010, 182: 261-268. 10.1164/rccm.200909-1347OC.CrossRefPubMed
21.
go back to reference Rodat-Despoix L, Crevel H, Marthan R, Savineau JP, Guibert C: Heterogeneity in 5-HT-induced contractile and proliferative responses in rat pulmonary arterial bed. J Vasc Res. 2008, 45: 181-192. 10.1159/000111071.CrossRefPubMed Rodat-Despoix L, Crevel H, Marthan R, Savineau JP, Guibert C: Heterogeneity in 5-HT-induced contractile and proliferative responses in rat pulmonary arterial bed. J Vasc Res. 2008, 45: 181-192. 10.1159/000111071.CrossRefPubMed
22.
go back to reference Rodat L, Savineau JP, Marthan R, Guibert C: Effect of chronic hypoxia on voltage-independent calcium influx activated by 5-HT in rat intrapulmonary arteries. Pflugers Arch. 2007, 454: 41-51. 10.1007/s00424-006-0178-y.CrossRefPubMed Rodat L, Savineau JP, Marthan R, Guibert C: Effect of chronic hypoxia on voltage-independent calcium influx activated by 5-HT in rat intrapulmonary arteries. Pflugers Arch. 2007, 454: 41-51. 10.1007/s00424-006-0178-y.CrossRefPubMed
23.
go back to reference Guibert C, Savineau JP, Crevel H, Marthan R, Rousseau E: Effect of short-term organoid culture on the pharmaco-mechanical properties of rat extra- and intrapulmonary arteries. Br J Pharmacol. 2005, 146: 692-701. 10.1038/sj.bjp.0706379.CrossRefPubMedPubMedCentral Guibert C, Savineau JP, Crevel H, Marthan R, Rousseau E: Effect of short-term organoid culture on the pharmaco-mechanical properties of rat extra- and intrapulmonary arteries. Br J Pharmacol. 2005, 146: 692-701. 10.1038/sj.bjp.0706379.CrossRefPubMedPubMedCentral
24.
go back to reference Keegan A, Morecroft I, Smillie D, Hicks MN, MacLean MR: Contribution of the 5-HT(1B) receptor to hypoxia-induced pulmonary hypertension: converging evidence using 5-HT(1B)-receptor knockout mice and the 5-HT(1B/1D)-receptor antagonist GR127935. Circ Res. 2001, 89: 1231-1239. 10.1161/hh2401.100426.CrossRefPubMed Keegan A, Morecroft I, Smillie D, Hicks MN, MacLean MR: Contribution of the 5-HT(1B) receptor to hypoxia-induced pulmonary hypertension: converging evidence using 5-HT(1B)-receptor knockout mice and the 5-HT(1B/1D)-receptor antagonist GR127935. Circ Res. 2001, 89: 1231-1239. 10.1161/hh2401.100426.CrossRefPubMed
25.
go back to reference MacLean MR, Sweeney G, Baird M, McCulloch KM, Houslay M, Morecroft I: 5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats. Br J Pharmacol. 1996, 119: 917-930.CrossRefPubMedPubMedCentral MacLean MR, Sweeney G, Baird M, McCulloch KM, Houslay M, Morecroft I: 5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats. Br J Pharmacol. 1996, 119: 917-930.CrossRefPubMedPubMedCentral
26.
go back to reference Sauvageau S, Thorin E, Villeneuve L, Dupuis J: Change in pharmacological effect of endothelin receptor antagonists in rats with pulmonary hypertension: role of ETB-receptor expression levels. Pulm Pharmacol Ther. 2009, 22: 311-317. 10.1016/j.pupt.2009.01.006.CrossRefPubMedPubMedCentral Sauvageau S, Thorin E, Villeneuve L, Dupuis J: Change in pharmacological effect of endothelin receptor antagonists in rats with pulmonary hypertension: role of ETB-receptor expression levels. Pulm Pharmacol Ther. 2009, 22: 311-317. 10.1016/j.pupt.2009.01.006.CrossRefPubMedPubMedCentral
27.
go back to reference MacLean MR, McCulloch KM, Baird M: Endothelin ETA- and ETB-receptor-mediated vasoconstriction in rat pulmonary arteries and arterioles. J Cardiovasc Pharmacol. 1994, 23: 838-845. 10.1097/00005344-199405000-00022.CrossRefPubMed MacLean MR, McCulloch KM, Baird M: Endothelin ETA- and ETB-receptor-mediated vasoconstriction in rat pulmonary arteries and arterioles. J Cardiovasc Pharmacol. 1994, 23: 838-845. 10.1097/00005344-199405000-00022.CrossRefPubMed
28.
go back to reference Mam V, Tanbe AF, Vitali SH, Arons E, Christou HA, Khalil RA: Impaired vasoconstriction and nitric oxide-mediated relaxation in pulmonary arteries of hypoxia- and monocrotaline-induced pulmonary hypertensive rats. J Pharmacol Exp Ther. 2010, 332: 455-462. 10.1124/jpet.109.160119.CrossRefPubMedPubMedCentral Mam V, Tanbe AF, Vitali SH, Arons E, Christou HA, Khalil RA: Impaired vasoconstriction and nitric oxide-mediated relaxation in pulmonary arteries of hypoxia- and monocrotaline-induced pulmonary hypertensive rats. J Pharmacol Exp Ther. 2010, 332: 455-462. 10.1124/jpet.109.160119.CrossRefPubMedPubMedCentral
29.
go back to reference Bonnet S, Dubuis E, Vandier C, Martin S, Marthan R, Savineau JP: Reversal of chronic hypoxia-induced alterations in pulmonary artery smooth muscle electromechanical coupling upon air breathing. Cardiovasc Res. 2002, 53: 1019-1028. 10.1016/S0008-6363(01)00548-X.CrossRefPubMed Bonnet S, Dubuis E, Vandier C, Martin S, Marthan R, Savineau JP: Reversal of chronic hypoxia-induced alterations in pulmonary artery smooth muscle electromechanical coupling upon air breathing. Cardiovasc Res. 2002, 53: 1019-1028. 10.1016/S0008-6363(01)00548-X.CrossRefPubMed
30.
go back to reference Hyvelin JM, Guibert C, Marthan R, Savineau JP: Cellular mechanisms and role of endothelin-1-induced calcium oscillations in pulmonary arterial myocytes. Am J Physiol. 1998, 275: L269-282.PubMed Hyvelin JM, Guibert C, Marthan R, Savineau JP: Cellular mechanisms and role of endothelin-1-induced calcium oscillations in pulmonary arterial myocytes. Am J Physiol. 1998, 275: L269-282.PubMed
31.
go back to reference Ivy D, McMurtry IF, Yanagisawa M, Gariepy CE, Le Cras TD, Gebb SA, Morris KG, Wiseman RC, Abman SH: Endothelin B receptor deficiency potentiates ET-1 and hypoxic pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol. 2001, 280: L1040-1048.PubMed Ivy D, McMurtry IF, Yanagisawa M, Gariepy CE, Le Cras TD, Gebb SA, Morris KG, Wiseman RC, Abman SH: Endothelin B receptor deficiency potentiates ET-1 and hypoxic pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol. 2001, 280: L1040-1048.PubMed
32.
go back to reference Guibert C, Marthan R, Savineau JP: 5-HT induces an arachidonic acid-sensitive calcium influx in rat small intrapulmonary artery. Am J Physiol Lung Cell Mol Physiol. 2004, 286: L1228-1236. 10.1152/ajplung.00265.2003.CrossRefPubMed Guibert C, Marthan R, Savineau JP: 5-HT induces an arachidonic acid-sensitive calcium influx in rat small intrapulmonary artery. Am J Physiol Lung Cell Mol Physiol. 2004, 286: L1228-1236. 10.1152/ajplung.00265.2003.CrossRefPubMed
33.
go back to reference McDaniel SS, Platoshyn O, Wang J, Yu Y, Sweeney M, Krick S, Rubin LJ, Yuan JX: Capacitative Ca(2+) entry in agonist-induced pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol. 2001, 280: L870-880.PubMed McDaniel SS, Platoshyn O, Wang J, Yu Y, Sweeney M, Krick S, Rubin LJ, Yuan JX: Capacitative Ca(2+) entry in agonist-induced pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol. 2001, 280: L870-880.PubMed
34.
go back to reference Shimoda LA, Sylvester JT, Sham JS: Mobilization of intracellular Ca(2+) by endothelin-1 in rat intrapulmonary arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2000, 278: L157-164.PubMed Shimoda LA, Sylvester JT, Sham JS: Mobilization of intracellular Ca(2+) by endothelin-1 in rat intrapulmonary arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2000, 278: L157-164.PubMed
35.
go back to reference Barman SA: Vasoconstrictor effect of endothelin-1 on hypertensive pulmonary arterial smooth muscle involves Rho-kinase and protein kinase C. Am J Physiol Lung Cell Mol Physiol. 2007, 293: L472-479. 10.1152/ajplung.00101.2006.CrossRefPubMed Barman SA: Vasoconstrictor effect of endothelin-1 on hypertensive pulmonary arterial smooth muscle involves Rho-kinase and protein kinase C. Am J Physiol Lung Cell Mol Physiol. 2007, 293: L472-479. 10.1152/ajplung.00101.2006.CrossRefPubMed
36.
go back to reference Rodat-Despoix L, Aires V, Ducret T, Marthan R, Savineau JP, Rousseau E, Guibert C: Signalling pathways involved in the contractile response to 5-HT in human pulmonary artery. Eur Respir J. 2009, 34: 1338-1347. 10.1183/09031936.00143808.CrossRefPubMed Rodat-Despoix L, Aires V, Ducret T, Marthan R, Savineau JP, Rousseau E, Guibert C: Signalling pathways involved in the contractile response to 5-HT in human pulmonary artery. Eur Respir J. 2009, 34: 1338-1347. 10.1183/09031936.00143808.CrossRefPubMed
37.
go back to reference Sauzeau V, Le Jeune H, Cario-Toumaniantz C, Smolenski A, Lohmann SM, Bertoglio J, Chardin P, Pacaud P, Loirand G: Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. J Biol Chem. 2000, 275: 21722-21729. 10.1074/jbc.M000753200.CrossRefPubMed Sauzeau V, Le Jeune H, Cario-Toumaniantz C, Smolenski A, Lohmann SM, Bertoglio J, Chardin P, Pacaud P, Loirand G: Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle. J Biol Chem. 2000, 275: 21722-21729. 10.1074/jbc.M000753200.CrossRefPubMed
38.
go back to reference de Wit C, Griffith TM: Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses. Pflugers Arch. 2010, 459: 897-914. 10.1007/s00424-010-0830-4.CrossRefPubMed de Wit C, Griffith TM: Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses. Pflugers Arch. 2010, 459: 897-914. 10.1007/s00424-010-0830-4.CrossRefPubMed
Metadata
Title
Role of the gap junctions in the contractile response to agonists in pulmonary artery from two rat models of pulmonary hypertension
Authors
Marie Billaud
Diana Dahan
Roger Marthan
Jean-Pierre Savineau
Christelle Guibert
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2011
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-12-30

Other articles of this Issue 1/2011

Respiratory Research 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.